Correspondence
THE ONCOLOGY INSTITUTE, INC.
18000 Studebaker Road, Suite 800
Cerritos, CA 90703
June 16, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attn: Robert Augustin
| Re: | The Oncology Institute, Inc. | |
| Registration Statement on Form S-3, filed June 6, 2025 | ||
| File No. 333-287138 |
Dear Mr. Augustin:
In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, The Oncology Institute, Inc. (the “Company”) hereby requests acceleration of the effective date of the above-referenced Registration Statement on Form S-3 (File No. 333-287848) (the “Registration Statement”), as amended on June 16, 2025. The Company respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern Time, on June 18, 2025 or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Latham & Watkins LLP, by calling Steven B. Stokdyk at (213) 891-7421.
| Very truly yours, | ||
| THE ONCOLOGY INSTITUTE, INC. | ||
| /s/ Robert Carter | ||
| Robert Carter | ||
| Chief Financial Officer |
| cc: | Daniel Virnich, The Oncology Institute, Inc. Steven B. Stokdyk, Latham & Watkins LLP Brent T. Epstein, Latham & Watkins LLP |